Search results
Showing 826 to 840 of 1361 results for social care
medicines and medicines-related patient safety incidents, compared with usual care or other interventions, in children? Any explanatory...
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Selective dorsal rhizotomy for spasticity in cerebral palsy (HTG245)
Evidence-based recommendations on selective dorsal rhizotomy for spasticity in cerebral palsy. This involves cutting nerves in the lower spine that are responsible for muscle rigidity.
View recommendations for HTG245Show all sections
Sections for HTG245
This guide outlines the main elements of the interim process and methods for the NICE clinical guideline updates using standing committees pilot programme, including details of the Clinical Guidelines Updates committee, which were agreed by the NICE Board in September 2013
NICE has developed a medtech innovation briefing (MIB) on RT300 for spinal cord injury rehabilitation .
delivered alone or in combination (in conjunction with standard care) compared with standard care alone for young people...
Recommendation ID NG181/6 Question Is an integrated care system effective at promoting successful progress for people with complex...
to address the needs of older people. It is also unclear if health and social care practitioners fully understand the purpose of the...
This guideline covers identifying and managing otitis media with effusion (OME), also known as ‘glue ear’, in children younger than 12 years. It aims to improve hearing and quality of life in children with OME.
Evidence-based recommendations on durvalumab (Imfinzi) for locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation in adults.
Patisiran for treating hereditary transthyretin amyloidosis (HST10)
Evidence-based recommendations on patisiran (Onpattro) for treating hereditary transthyretin amyloidosis in adults with stage 1 and stage 2 polyneuropathy.
Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care.